Invitae Expanded Genetic Testing Menu
Invitae has expanded its genetic testing menu. It now offers more neurological tests, a greater number of pediatric and rare disease tests, and new inherited metabolic disorders and newborn screening confirmation. The expanded neurological testing includes more than 30 disorders, such as muscular dystrophies, myopathies, congenital myasthenic syndrome, and malignant hyperthermia susceptibility. The expanded pediatric and rare disease testing covers more than 60 disorders, including severe combined immunodeficiency, periodic fever syndromes, and 20 new rare diseases. The company's new inherited metabolic disorders and newborn screening confirmation covers the majority of metabolic diseases, plus a panel for the common congenital disorders of glycosylation.
Fluxion BioFlux Extended Flow Module
Fluxion Biosciences has launched its BioFlux Extended Flow module for live cell analysis. The module consists of a new 6-well plate consumable and interface. It is targeted to applications requiring longer cell or microbial growth under flow conditions. The new consumable extends the flow time from 31 hours using BioFlux 24-well plates at a shear of 1 dyn/cm2 to 110 hours at the same shear using the new extended flow plates, the company said. At low flow rates (0.15 dyn/cm2), BioFlux channels can be kept under perfusion for up to 21 days, important for applications in tuberculosis and urinary tract infection research. The system enables a multitude of assays that require precise control of the cellular microenvironment, including control of shear forces, liquid composition, gas, and temperature.
For more new products and services, please visit the New Products page on our website.